These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 18421578

  • 1. Death receptor-4 (DR4) expression is regulated by transcription factor NF-kappaB in response to etoposide treatment.
    Mendoza FJ, Ishdorj G, Hu X, Gibson SB.
    Apoptosis; 2008 Jun; 13(6):756-70. PubMed ID: 18421578
    [Abstract] [Full Text] [Related]

  • 2. Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1.
    Shetty S, Graham BA, Brown JG, Hu X, Vegh-Yarema N, Harding G, Paul JT, Gibson SB.
    Mol Cell Biol; 2005 Jul; 25(13):5404-16. PubMed ID: 15964798
    [Abstract] [Full Text] [Related]

  • 3. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5.
    Choi SY, Kim MJ, Chung HY, Lee SJ, Jang YJ.
    Oncol Rep; 2007 Jan; 17(1):175-84. PubMed ID: 17143496
    [Abstract] [Full Text] [Related]

  • 4. Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-kappaB in prostatic carcinoma cell lines.
    Guseva NV, Taghiyev AF, Sturm MT, Rokhlin OW, Cohen MB.
    Mol Cancer Res; 2004 Oct; 2(10):574-84. PubMed ID: 15498932
    [Abstract] [Full Text] [Related]

  • 5. IFN-gamma/JAK/STAT pathway-induced inhibition of DR4 and DR5 expression on endothelial cells is cancelled by cycloheximide-sensitive mechanism: novel finding of cycloheximide-regulating death receptor expression.
    Tanaka F, Kawakami A, Tamai M, Nakamura H, Iwanaga N, Izumi Y, Arima K, Aratake K, Huang M, Kamachi M, Ida H, Origuchi T, Eguchi K.
    Int J Mol Med; 2005 May; 15(5):833-9. PubMed ID: 15806306
    [Abstract] [Full Text] [Related]

  • 6. Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4.
    Kurbanov BM, Fecker LF, Geilen CC, Sterry W, Eberle J.
    Oncogene; 2007 May 17; 26(23):3364-77. PubMed ID: 17160022
    [Abstract] [Full Text] [Related]

  • 7. TNF-alpha induces transient resistance to Fas-induced apoptosis in eosinophilic acute myeloid leukemia cells.
    Qin Y, Auh S, Blokh L, Long C, Gagnon I, Hamann KJ.
    Cell Mol Immunol; 2007 Feb 17; 4(1):43-52. PubMed ID: 17349210
    [Abstract] [Full Text] [Related]

  • 8. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
    Lu ZG, Liu H, Yamaguchi T, Miki Y, Yoshida K.
    Cancer Res; 2009 Jul 15; 69(14):5927-35. PubMed ID: 19549902
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
    Uwagawa T, Li Z, Chang Z, Xia Q, Peng B, Sclabas GM, Ishiyama S, Hung MC, Evans DB, Abbruzzese JL, Chiao PJ.
    Cancer; 2007 May 15; 109(10):2142-53. PubMed ID: 17410536
    [Abstract] [Full Text] [Related]

  • 10. NF-κB induces abnormal centrosome amplification by upregulation of CDK2 in laryngeal squamous cell cancer.
    Liu JL, Ma HP, Lu XL, Sun SH, Guo X, Li FC.
    Int J Oncol; 2011 Oct 15; 39(4):915-24. PubMed ID: 21769424
    [Abstract] [Full Text] [Related]

  • 11. Evidence that the human death receptor 4 is regulated by activator protein 1.
    Guan B, Yue P, Lotan R, Sun SY.
    Oncogene; 2002 May 09; 21(20):3121-9. PubMed ID: 12082627
    [Abstract] [Full Text] [Related]

  • 12. Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells.
    Braeuer SJ, Büneker C, Mohr A, Zwacka RM.
    Mol Cancer Res; 2006 Oct 09; 4(10):715-28. PubMed ID: 17050666
    [Abstract] [Full Text] [Related]

  • 13. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier.
    Ye D, Ma I, Ma TY.
    Am J Physiol Gastrointest Liver Physiol; 2006 Mar 09; 290(3):G496-504. PubMed ID: 16474009
    [Abstract] [Full Text] [Related]

  • 14. p53 upregulates death receptor 4 expression through an intronic p53 binding site.
    Liu X, Yue P, Khuri FR, Sun SY.
    Cancer Res; 2004 Aug 01; 64(15):5078-83. PubMed ID: 15289308
    [Abstract] [Full Text] [Related]

  • 15. Regulation of glutathione S-transferase P1-1 gene expression by NF-kappaB in tumor necrosis factor alpha-treated K562 leukemia cells.
    Morceau F, Duvoix A, Delhalle S, Schnekenburger M, Dicato M, Diederich M.
    Biochem Pharmacol; 2004 Apr 01; 67(7):1227-38. PubMed ID: 15013838
    [Abstract] [Full Text] [Related]

  • 16. MEKK1-induced apoptosis requires TRAIL death receptor activation and is inhibited by AKT/PKB through inhibition of MEKK1 cleavage.
    Bild AH, Mendoza FJ, Gibson EM, Huang M, Villanueva J, Garrington TP, Jove R, Johnson GL, Gibson SB.
    Oncogene; 2002 Sep 26; 21(43):6649-56. PubMed ID: 12242663
    [Abstract] [Full Text] [Related]

  • 17. Nuclear factor-kappaB dimer exchange promotes a p21(waf1/cip1) superinduction response in human T leukemic cells.
    Chang PY, Miyamoto S.
    Mol Cancer Res; 2006 Feb 26; 4(2):101-12. PubMed ID: 16513841
    [Abstract] [Full Text] [Related]

  • 18. Proapoptotic effects of NF-kappaB on cisplatin-induced cell death in auditory cell line.
    Chung WH, Boo SH, Chung MK, Lee HS, Cho YS, Hong SH.
    Acta Otolaryngol; 2008 Oct 26; 128(10):1063-70. PubMed ID: 18607991
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sp1 is involved in 8-chloro-adenosine-upregulated death receptor 5 expression in human hepatoma cells.
    Sun M, Zhang J, Liu S, Liu Y, Zheng D.
    Oncol Rep; 2008 Jan 26; 19(1):177-85. PubMed ID: 18097593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.